Jessica Kirshner

This inventor holds 33 USPTO granted patents and 12 published patent applications, plus 7 CIPO patents and 13 EPO patents, primarily in Antibody Therapeutics. Top assignees: Regeneron Pharmaceuticals, Inc., Regeneran Pharmaceuticals, Inc.. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jessica Kirshner. Retrieved from https://idiyas.com/inventor/jessica-kirshner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33 (Patent Applications = 12)

% Patents Active = 97.0

CIPO Patents = 7 (Patent Applications = 13)

EPO Patents = 13 (Patent Applications = 24)

Average Co-Inventor Count = 6.3

ph-index = 5

Forward Citations = 158(Granted Patents)

Company Filing History:

30 out of 1,479

Regeneron Pharmaceuticals, Inc.

patents

3 out of 49

Regeneran Pharmaceuticals, Inc.

patents

Years Active: 2016-2026

Loading Chart...

Areas of Expertise:

Antibody Compositions

Tumor Treatment

Bispecific Antibodies

HPV Antigen-Binding Proteins

CD3 Antigen

MUC16

PSMA

EGFRvIII

PRLR

BCMA

STEAP2

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12747300 - Methods and Antibody Compositions for Tumor Treatment (2026-09-29),

2. 12600783 - ANTI-NEW YORK ESOPHAGEAL SQUAMOUS CELL CARCINOMA 1 (NY-ESO-1) ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF (2026-04-14),

3. 12590168 - ANTIGEN-BINDING MOLECULES THAT BIND CD38 AND/OR CD28, AND USES THEREOF (2026-03-31),

4. 12570764 - Anti-MUC16 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind MUC16 and CD3, and uses thereof (2026-03-10),

5. 12344677 - Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof (2025-07-01),

6. 12258412 - Nucleic acid molecules encoding bispecific anti-BCMA x anti-CD3 antibodies (2025-03-25),

7. 12150959 - Chimeric antigen receptors with BCMA specificity and uses thereof (2024-11-26),

8. 12115216 - Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof (2024-10-15),

9. 12091460 - Use of bispecific antigen-binding molecules that bind MUC16 and CD3 in combination with 4-1BB co-stimulation (2024-09-17),

10. 11905332 - Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof (2024-02-20),

11. 11633501 - Anti-STEAP2 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind STEAP2 and CD3, and uses thereof (2023-04-25),

12. 11608380 - Anti-EGFRvIII antibodies and uses thereof (2023-03-21),

13. 11559576 - Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof (2023-01-24),

14. 11485793 - Anti-MUC16 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind MUC16 and CD3, and uses thereof (2022-11-01),

15. 11434300 - Methods and antibody compositions for tumor treatment (2022-09-06),

Title: The Innovative Journey of Jessica Kirshner

Introduction: Jessica Kirshner, a pioneering inventor based in New York, NY, has been making waves in the world of technology with her groundbreaking creations.

Latest Patents: Jessica Kirshner's most recent patents include a cutting-edge wearable device that revolutionizes the healthcare industry by monitoring vital signs in real-time and a sustainable packaging solution that reduces environmental impact.

Career Highlights: With a background in engineering and a passion for problem-solving, Jessica Kirshner has successfully brought numerous inventions from concept to reality. Her innovative spirit and dedication to improving people's lives have earned her recognition as a leading figure in the field.

Collaborations: Jessica Kirshner has collaborated with top research institutions and universities to further her research and development efforts. Her partnerships with industry experts have led to the creation of groundbreaking technologies that have the potential to shape the future.

Conclusion: Jessica Kirshner's relentless pursuit of innovation and her commitment to pushing the boundaries of what is possible make her a true trailblazer in the world of inventions. Her impact on the industry is undeniable, and her work continues to inspire the next generation of inventors.

Profile summary based on public USPTO records.